PTPN2 and anaplastic large cell lymphoma: Furthermore, loss of PTPN1 and PTPN2 expression was recently identified as an important driver of anaplastic large cell lymphoma (ALCL) resistance to anaplastic lymphoma kinase (ALK) inhibitors [24].